Autonomic nervous system dysfunction involving the gastrointestinal and the urinary tracts in primary Sjögren's syndrome

Clinical and Experimental Rheumatology

Volumn 21, Issue 6, 2003, Pages 697-703

  Kovács, László ^a   Papos M ^a   Takacs R ^a   Roka R ^a   Csenke, Z ^b   Kovacs A ^a   Varkonyi T ^a   Pajor, L ^c   Pavics L ^a   Pokorny, G ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Division of Urology   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Anti muscarinic acetylcholine receptor antibodies; Autonomic dysfunction; Gastric emptying scintigraphy; Primary Sj gren's syndrome; Urodynamic studies

Indexed keywords

AUTOANTIBODY; MUSCARINIC M3 RECEPTOR; RECEPTOR ANTIBODY; RECEPTOR SUBTYPE;

ADULT; AGED; ARTICLE; AUTONOMIC NEUROPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DETRUSOR MUSCLE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE HYPOTONIA; PATHOGENESIS; PRIORITY JOURNAL; SJOEGREN SYNDROME; SMOOTH MUSCLE CONTRACTILITY; STOMACH EMPTYING; STOMACH SCINTISCANNING; SYMPTOMATOLOGY; URINARY TRACT DISEASE; URODYNAMICS;

ADULT; AGE DISTRIBUTION; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL DISEASES; HUMANS; INCIDENCE; LINEAR MODELS; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SJOGREN'S SYNDROME; STATISTICS, NONPARAMETRIC; URODYNAMICS; UROLOGIC DISEASES;

EID: 10744220706     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. JONSSON R, HAGA HJ, GORDON TP: Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome. Scand J Rheumatol 2000; 29: 341-8.
2. KOVÁCS L, TÖRÖK T, BARI F et al.: Impaired microvascular response to cholinergic stimuli in primary Sjögren's syndrome. Ann Rheum Dis 2000; 59: 48-53.
3. BACMAN S, STERIN-BORDA L, JOSÉ CAMUSSO J, ARANA R, HUBSCHER O, BORDA E: Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome. Clin Exp Immunol 1996; 104: 454-9.
4. null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome. Proc Natl Acad Sci USA 1998; 95: 7538-43.
5. BACMAN S, BERRA A, STERIN-BORDA L, BORDA E: Muscarinic acetylcholine receptor antibodies as a new marker of dry eye in Sjögren's syndrome. Invest Ophthalmol Vis Sci 2001; 42: 321-327.
6. STENGEL PW, YAMADA M, WESS J, COHEN ML: M3 receptor knockout mice muscarinic receptor function in atria, stomach fundus, urinary bladder and trachea. Am J Physiol Regul Integr Comp Physiol 2002; 282: R1443-9.
7. CHESS-WILLIAMS R, CHAPPLE CR, YAMANISHI T, YASUDA K, SELLERS DJ: The minor population of M3 receptors mediate contraction of human detrusor muscle in vitro. J Auton Pharmacol 2001; 21: 243-8.
8. HOROWITZ M, FRASER RJL, HEBBARD GS, JONES KL, WISHART JM, SUN WM: Effects of diabetes mellitus on gastrointestinal motor function. Neurosci Res Comm 1997; 21: 75-82.
9. MANDL T, JACOBSSON L, LILJA B, SUNDKVIST G, MANTHORPE R: Disturbances of autonomic nervous function in primary Sjögren's syndrome. Scand J Rheumatol 1997; 26: 401-6.
10. ANDONOPOULOS AP, CHRISTODOULOU J, BALLAS C, BOUNAS A, ALEXOPOULOS D: Autonomic cardiovascular neuropathy in Sjögren's syndrome. A controlled study. J Rheumatol 1998; 25: 2385-8.
11. BARENDREGT PJ, van den MEIRACKER AH, MARKUSSE HM et al.: Parasympathetic failure does not contribute to ocular dryness in primary Sjögren's syndrome. Ann Rheum Dis 1999; 58: 746-750.
12. TUMIATI B, PERAZZOLI F, NEGRO A, PANTALEONI M, REGOLISTI G: Heart rate variability in patients with Sjögren's syndrome. Clin Rheumatol 2000; 19: 477-480.
13. NIEMELA RK, PIKKUJAMSA SM, HAKALA M, HUIKURI HV, AIRAKSINEN KEJ: No signs of autonomic nervous system dysfunction in primary Sjögren's syndrome evaluated by 24 hour heart rate variability. J Rheumatol 2000; 27: 2605-10.
14. MANDL T, BORNMYR SV, CASTENFORS J, JACOBSSON LTH, MANTHORPE R, WOLLMER P: Sympathetic dysfunction in patients with primary Sjögren's syndrome. J Rheumatol 2001; 28: 296-301.
15. BARENDREGT PJ, TULEN JHM, van den MEIRACKER AH, MARKUSSE HM: Spectral analysis of heart rate and blood pressure variability in primary Sjögren's syndrome. Ann Rheum Dis 2002; 61: 232-6.
16. VITALI C, BOMBARDIERI S, JONSSON R et al.: Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the Ameridan-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
17. FRIMODT MOLLER C, HALD T: Clinical urodynamics. Methods and results. Scand J Urol Nephrol 1973; 6 (Suppl 15):143-155.
18. KOHLER PF, WINTER ME: A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer Test. Arthritis Rheum 1985; 28: 1128-32.
19. GEMIGNANI F, MANGANELLI P, PAVESI G, MARBINI A: Polyneuropathy in Sjögren's syndrome. A case of prevalently autonomic neuropathy with tonic pupil and hypohidrosis. Funct Neurol 1988; 3: 337-48.
20. WATERSCHOOT MP, GUERIT JM, LAMBERT M, de BARSY T: Bilateral tonic pupils and polyneuropathy in Sjögren's syndrome: A common pathophysiological mechanism? Eur Nerol 1991; 31: 114-116.
21. SORAJJA P, POIRIER MK, BUNDRICK JB, MATTESON EL: Autonomic failure and proximal skeletal myopathy in a patient with primary Sjögren's syndrome. Mayo Clin Proc 1999; 74(7): 695-7.
22. GEATTI O, SHAPIRO B, FIG LM et al.: Radiolabelled semisolid test meal clearance in the evaluation of esophageal involvement in scleroderma and Sjögren's syndrome. Am J Physiol Imaging 1991; 6: 65-73.
23. VÁRKONYI TT, FARKAS G, FÜLÖP ZS et al.: Beneficial effect of fetal islet grafting on development of late diabetic complications. Transplant Proc 1998; 30: 330-331.
24. CAMILLERI M, MALAGELADA J: Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 1984; 14: 420-7.
25. SAMSOM M, AKKERMANS LMA, JEBBINK RJA, ISSELT H, van BERGE-HENEGOUWEN J, SMOUT AJPM: Gastrointestinal motor mechanisms in hyperglycemia induced delayed gastric emptying in type 1 diabetes mellitus. Gut 1997; 40: 641-6.
26. GOUGAS G, EAKER EY, ABELL TL et al.: Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000; 95: 1456-62.
27. PARKMAN HP, TRATE DM, KNIGHT LC, BROWN KL, MAURER AH, FISHER RS: Cholinergic effects on human gastric motility. Gut 1999; 45: 346-54
28. ROSZTÓCZY A, KOVÁCS L, WITTMANN T, LONOVICS J, POKORNY G: Manometric assessment of impaired esophageal motor function in primary Sjögren's syndrome. Clin Exp Rheumatol 2001; 19: 147-152.
29. WATERMAN SA, GORDON TP, RISCH-MUELLER M: Inhibitory effects of muscarinic recepor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum 2000; 43:1647-54.
30. KAPLAN SA, TE AE, BLAIVAS JG: Urodynamic findings in patients with diabetic cystopathy. J Urol 1995; 153: 342-4.
31. KEMPLER P, KÁDÁR É, MARTON A, VARGHA P, HERMÁNYI ZS, KERESZTES K: Sensory nerve dysfunction in NIDDM and in newly diagnosed NIDDM detected by the Neurometer: Relation to autonomic function. In HOTTA N, GREENE DA, WARD DJ, SIMA AAF, BOULTON AJM (Eds.): Diabetic Neuropathy: New Concepts and Insights. Amsterdam, Elsevier Science B.V. 1995:291-296.
32. TESFAYE S, STEVENS LK, STEPHENSON JM et al. and the EURODIAB IDDM Study Group: Prevalence of diabetic peripheral neuropathy and its relation to glycemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1377-1384.
33. SAMSOM M, ROELOFS JMM, AKKERMANS LMA, van BERGE-HENEGOUWEN J, SMOUT AJPM: Proximal gastric motor activity in response to a liquid meal in type 1 diabetes mellitus with autonomic neuropathy. Dig Dis Sci 1998; 43: 491-6.
34. DENISLIC M, MEH D: Neurophysiological assessment of peripheral neuropathy in primary Sjögren's syndrome. Clin Investig 1994; 72: 822-9.
35. GOLDBLATT F, GORDON TP, WATERMAN S: Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 2002; 123: 1144-50.